Intec Pharma Ltd. (Nasdaq:NTEC), a biopharmaceutical company developing a treatment for Parkinson’s disease symptoms in advanced Parkinson’s disease patients, will visit the Nasdaq MarketSite in Times Square in observance of World Parkinson’s Day.
In honor of the occasion, Jeffrey A. Meckler, Chief Executive Officer and Vice Chairman of the Board, will ring the Closing Bell.